COMP <GO>
AHR vs BRK-A // FORWARD P/E MULTIPLE
American Healthcare REIT Inc. (NYSE) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: AHR 3
— BRK-A 8
■ METRIC PARITY
LAST: $53.79 (+0.50%) • MKT CAP: $12.48B
forward-pe
—
LAST: $834,640.73 (+2.34%) • MKT CAP: $1.20T
forward-pe
24.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHR VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHR | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.10% | 11.47% | -3.37 | BRK-A | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.4x | 9.7x | +16.72 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 1.62% | 2.09% | -0.47 | BRK-A | /fcf-yield <GO> |
| Operating Margin | 19.80% | 27.80% | -8.00 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 22.30% | -18.90 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 3.93% | +7.27 | AHR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.32% | 0.00% | +1.32 | AHR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | AHR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.5 | 66.0 | -11.50 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.13 | -0.02 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 24.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.48B | $1.20T | -$1.19T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHR REV | BRK-A REV | AHR GROSS % | BRK-A GROSS % | AHR FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | $247.24B | — | — | $200.2M | $25.04B |
| FY 2024 | $1.88B | $249.71B | — | — | $91.3M | $11.62B |
| FY 2023 | $1.67B | $254.91B | — | — | $23.4M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHR // BETA 1.11
BRK-A // BETA 1.13